Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Apr 24, 2024 07:47 ET
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro),...
Apr 24, 2024 07:45 ET
Boscobel Releases Second Annual GovCon Journalism Survey Results
Boscobel Marketing Communications, the D.C.-area PR firm exclusively serving government contractors, announced today the release of its second annual report on government contracting journalism. The State of GovCon Journalism Survey 2024 explores...
Apr 24, 2024 07:30 ET
Avenue Therapeutics Announces Reverse Stock Split
Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that it will effect a...
Apr 24, 2024 07:30 ET
FirstService Reports First Quarter Results
FirstService Corporation (TSX: FSV; NASDAQ: FSV) today reported operating and financial results for its first quarter ended March 31, 2024. All amounts are in US dollars. Consolidated revenues for the first quarter were $1.16 billion, up 14%...
Apr 24, 2024 07:30 ET
Amesite Launches Revolutionary NurseMagic™ App in Beta to Empower 5.2 Million Nurses with AI Tools
Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, today announced the beta release of NurseMagic™, an innovative and proprietary app designed...
Apr 24, 2024 07:30 ET
AppTech Payments to Present at the Planet MicroCap Showcase: Vegas 2024
AppTech Payments Corp. (Nasdaq: APCX) (“AppTech” or the “Company”), a pioneering Fintech company powering frictionless commerce, announces that Luke D’Angelo, Chief Executive Officer, will present a corporate overview at the Planet MicroCap...
Apr 24, 2024 07:30 ET
Canada’s Industry Leaders Unite to Tackle Plastic Waste with Launch of Unnecessary & Problematic Plastics Guidance
The Canada Plastics Pact (CPP), in partnership with the National Zero Waste Council, has released guidance for industry to take urgent measures to eliminate unnecessary and problematic plastics. The guidance includes a list of 13 unnecessary or...
Apr 24, 2024 07:30 ET
Highland Copper Announces the Successful Completion of the White Pine North Winter Drilling Program
Highland Copper Company Inc. (TSXV: HI; OTCQB: HDRSF) (“Highland” or the “Company”) is pleased to announce that White Pine Copper LLC., its joint venture with Kinterra Copper USA LLC, has successfully completed its winter drilling program on the...
Apr 24, 2024 07:30 ET
InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
InflaRx N.V. (Nasdaq: IFRX), a biotechnology company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will participate in the Capital One Securities 1st Annual Biotech/Biopharma...
Apr 24, 2024 07:30 ET
Koryx Copper Intersects 207 Meters at 0.49% and 116 Meters at 0.54% Copper Equivalent
Significant copper and molybdenum intersections include: HM19: 116 m from near surface @ 0.54% CuEq HM20: 26.00 m @ 0.44% CuEq HM24: 44.00 m 0.32% CuEqHM36: 207 m @ 0.49% Cu Eq including 92.00 m @ 0.58% CuEq HM37: 255 m from surface @ 0.36% CuEq...
Apr 24, 2024 07:30 ET
Stock Yards Bancorp Reports First Quarter Earnings of $25.9 Million or $0.88 Per Diluted Share
Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today...
Apr 24, 2024 07:30 ET
The Habit Burger Grill Launches the Chicken Club Club, Offering Members a FREE Sandwich and Exclusive Perks
The Habit Burger Grill, the beloved California-born restaurant chain known for its flame-fresh chargrilled Charburgers, signature sandwiches, fresh salads, and creamy shakes, is excited to announce The Chicken Club Club, a positive space for...
Apr 24, 2024 07:30 ET
Tornado Global Hydrovacs Reports Record 2023 Results
Tornado Global Hydrovacs Ltd. (“Tornado” or the “Company”) (TSX-V: TGH; OTCQX: TGHLF) today reported its audited consolidated financial results for the year ended December 31, 2023, with comparisons to last year. The audited consolidated financial...
Apr 24, 2024 07:30 ET
United Community Banks, Inc. Reports First Quarter Results
United Community Banks, Inc. (NASDAQ: UCBI) (United) today announced that net income for the first quarter was $62.6 million and pre-tax, pre-provision income was $93.7 million. Diluted earnings per share of $0.51 for the quarter represented a...
Apr 24, 2024 07:30 ET
Watsco Reports Record First Quarter Sales, Record Cash Flow and Improving Business Trends Ahead of Summer Selling Season
Watsco, Inc. (NYSE: WSO) announced its operating results for the first quarter ended March 31, 2024 and provided commentary on business trends, growth opportunities, technology innovation and its financial position. With more than $7 billion in...
Apr 24, 2024 07:25 ET
Red Pine Intercepts Significant Mineralization at the Wawa Gold Project, including 5.34 g/t over 13.39 metres including 16.50 g/t gold over 0.97 metre and 13.62 g/t gold over 2.13 metres
Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company”) is pleased to announce assay results from 7 drill holes representing 2,538 metres (“m”) of diamond drilling from the 2023-2024 resource expansion program at the Wawa...
Apr 24, 2024 07:08 ET
Keiretsu Forum Sponsors Quix Labs at the Innovation Funders Showcase During Angel Capital Association's Annual Summit
Keiretsu Forum Mid-Atlantic, South-East, and Texas regions proudly announce their sponsorship of Quix Labs at the upcoming Innovation Funders Showcase during the 2024 Angel Capital Association (ACA) Summit. This event marks a significant step for...
Apr 24, 2024 07:05 ET
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
Travere Therapeutics, Inc., (Nasdaq: TVTX) and CSL Vifor today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the treatment of adults with primary IgA nephropathy (IgAN)...
Apr 24, 2024 07:01 ET
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the Company has received clearance from the U.S. Food and Drug Administration...